Dr. Reddy's Laboratories Ltd (RDY): Price and Financial Metrics

Dr. Reddy's Laboratories Ltd (RDY): $71.24

0.07 (-0.10%)

POWR Rating

Component Grades








RDY Price/Volume Stats

Current price $71.24 52-week high $77.72
Prev. close $71.31 52-week low $53.12
Day low $70.79 Volume 28,138
Day high $71.36 Avg. volume 193,167
50-day MA $74.45 Dividend yield 0.57%
200-day MA $69.41 Market Cap 11.89B

RDY Stock Price Chart Interactive Chart >

Dr. Reddy's Laboratories Ltd (RDY) Company Bio

Dr. Reddy's Laboratories operates as an integrated pharmaceutical company worldwide. It operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The company was founded in 1984 and is based in Hyderabad, India.

RDY Latest News Stream

Event/Time News Detail
Loading, please wait...

RDY Latest Social Stream

Loading social stream, please wait...

View Full RDY Social Stream

Latest RDY News From Around the Web

Below are the latest news stories about DR REDDYS LABORATORIES LTD that investors may wish to consider to help them evaluate RDY as an investment opportunity.

Dr. Reddy’s becomes first Indian pharma company to debut on the Dow Jones Sustainability World Index

HYDERABAD, India, December 14, 2023--Dr. Reddy’s has won back-to-back global recognitions for its commitment and progress on sustainability and Environment Social and Governance agenda.

Yahoo | December 14, 2023

Coya Therapeutics, Inc. and Dr. Reddy’s Laboratories Enter into an Exclusive Collaboration for Development and Commercialization of COYA 302, an Investigational Combination Therapy for Treatment of Amyotrophic Lateral Sclerosis (ALS)

HOUSTON & HYDERABAD, India & BASEL, Switzerland, December 06, 2023--Dr. Reddy's Laboratories SA, wholly-owned subsidiary of Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as "Dr. Reddy’s"), and Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya"), today announced that they have entered into a development and license agreement (the "Agreement") for the development and commercialization of COYA 302, an investigatio

Yahoo | December 6, 2023

Why Doctor Reddy's (RDY) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Yahoo | November 2, 2023

Dr. Reddy's (RDY) Q2 Earnings and Revenues Beat Estimates

Dr. Reddy's (RDY) reports better-than-expected fiscal second-quarter 2024 results where both earnings and revenues beat estimates, driven by growth in core businesses in North America and Europe.

Yahoo | October 30, 2023

Dr. Reddy’s Laboratories Limited (NYSE:RDY) Q2 2024 Earnings Call Transcript

Dr. Reddy’s Laboratories Limited (NYSE:RDY) Q2 2024 Earnings Call Transcript October 27, 2023 Dr. Reddy’s Laboratories Limited beats earnings expectations. Reported EPS is $1.07, expectations were $0.88. Operator: Ladies and gentlemen, good day, and welcome to the Dr. Reddy’s Q2 FY ’24 Earnings Conference Call. [Operator Instructions]. Please note that this conference is being recorded. […]

Yahoo | October 29, 2023

Read More 'RDY' Stories Here

RDY Price Returns

1-mo -2.46%
3-mo 4.93%
6-mo 7.58%
1-year 19.66%
3-year 11.56%
5-year 82.79%
YTD 2.39%
2023 36.16%
2022 -19.92%
2021 -7.49%
2020 76.61%
2019 8.38%

RDY Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full RDY Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!